NMTC (NeuroOne Medical Technologies) Tariff Resilience Score: 6/10 (As of Jul. 06, 2026)


NMTC NeuroOne Medical Technologies Corp NMTC
39 GF Score
Price $3.01
GF Value $6.61
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is NeuroOne Medical Technologies Tariff Resilience Score?

NeuroOne Medical Technologies NMTC -0.66% 39 Tariff Resilience Score is 6 as of Jul. 06, 2026. GuruFocus rates NMTC with a GF Score™ of 39/100 and a GF Value™ of $6.61 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 837 Medical Devices & Instruments companies, NeuroOne Medical Technologies ranks better than 91.04% on this metric.

NeuroOne Medical Technologies has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

NeuroOne Medical Technologies has Medical device company with some exposure to tariffs on imported components. However, its niche market and potential pricing power offer some resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes NeuroOne Medical Technologies might have Average Resilient.

NeuroOne Medical Technologies  (NAS:NMTC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

NeuroOne Medical Technologies Tariff Resilience Score Related Terms

NMTC vs RDGL, TANAF, MODD: Tariff Resilience Score Comparison

For the Medical Devices subindustry, NeuroOne Medical Technologies's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeuroOne Medical Technologies Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where NeuroOne Medical Technologies's Tariff Resilience Score falls into.


NMTC
39GF Score
NeuroOne Medical Technologies Corp NMTC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
NeuroOne Medical Technologies (NMTC) has a Tariff Resilience Score of 6 as of Jul. 06, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, NeuroOne Medical Technologies ranks #75 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 9%.
Is NeuroOne Medical Technologies' Tariff Resilience Score too high?
NeuroOne Medical Technologies' current Tariff Resilience Score is 6. Based on the distribution chart, NeuroOne Medical Technologies ranks #75 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, NeuroOne Medical Technologies has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does NeuroOne Medical Technologies' Tariff Resilience Score compare to RDGL and TANAF?
According to the Medical Devices & Instruments industry distribution chart, NeuroOne Medical Technologies ranks #75 out of 837 companies for Tariff Resilience Score. This places NeuroOne Medical Technologies in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. NeuroOne Medical Technologies's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuroOne Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, NeuroOne Medical Technologies (NMTC) is currently considered Possible Value Trap. The stock's GF Value™ is $6.61, compared to a current price of $3.01 — trading 54.5% below its estimated fair value. The current Tariff Resilience Score is 6. NeuroOne Medical Technologies' overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For NeuroOne Medical Technologies (NMTC), the current Tariff Resilience Score is 6 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeuroOne Medical Technologies (NMTC) Overvalued in 2026?

Based on GuruFocus' analysis, NeuroOne Medical Technologies stock appears to be undervalued. The current stock price of $3.01 is trading 54.5% below its estimated GF Value™ of $6.61. GuruFocus considers NeuroOne Medical Technologies to be Possible Value Trap.

Key valuation signals for NMTC:

  • Tariff Resilience Score: 6
  • GF Value™: $6.61 vs. price of $3.01 (54.5% below fair value)
  • GF Score™: 39/100 with 3 warning signs

No single metric tells the full story. See the NMTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeuroOne Medical Technologies Business Description

Address 7599 Anagram Drive, Eden Prairie, MN, USA, 55344
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
39GF Score

Get the complete analysis for NMTC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.01
Price
$6.61
GF Value